Whitney W Woodmansee

Whitney W Woodmansee, MD

Clinical Professor

Department: MD-ENDOCRINOLOGY
Business Phone: (352) 273-8655

About Whitney W Woodmansee

Whitney W. Woodmansee, MD is a Professor of Medicine in the University of Florida’s Division of Endocrinology, Diabetes and Metabolism, and is also the director for the Neuroendocrine/Pituitary Program and Thyroid Cancer Program.

Dr. Woodmansee completed her medical degree with honors at the University of Colorado Health Sciences Center. Following an internship and residency in Internal Medicine, she completed a fellowship in Endocrinology, Metabolism and Diabetes at the University of Colorado Health Sciences Center and is board-certified in Endocrinology.

Dr. Woodmansee’s work and participation in the field spans over a number of professional societies, including the Endocrine Society, Women in Endocrinology, American Thyroid Association and Pituitary Society. She has served on a number of journal editorial boards, including Endocrine Practice and Current Opinion in Endocrinology and Diabetes. Additionally, she has chaired both the Program and Development Committees for Women in Endocrinology and currently serves as President (2018-2020).

Accomplishments

Invited Symposium Speaker
2016 · 2016 Endocrine Society Meeting
Invited Participant and Session Chair
2013 · 9th International Consensus Conference dedicated to "Medical Treatment of Acromegaly"

Board Certifications

  • Endocrinology, Diabetes and Metabolism
    American Board of Internal Medicine

Clinical Profile

Specialties
  • Medicine
Subspecialties
  • Endocrinology, Diabetes and Metabolism
Areas of Interest
  • Cushing disease
  • Cushing syndrome
  • Hypopituitarism
  • Osteoporosis – overview
  • Pituitary tumor
  • Prolactinoma
  • Thyroid cancer
  • Thyroid diseases

Research Profile

Dr. Woodmansee has been involved in both basic science and clinical research and has numerous publications in the pituitary/thyroid field. Spending much of her career specializing in pituitary and thyroid disorders, she has also served as director of the Clinical Neuroendocrine Program at the Brigham and Women’s Hospital/ Harvard Medical School in Boston, MA and the medical director of the Neuroendocrine/Pituitary Program at the Mayo Clinic in Jacksonville, FL. Dr. Woodmansee has been a principal investigator in a number of clinical trials related to pituitary disorders and her current primary research interest is in the area of hypopituitarism. She specializes in treating patients with pituitary and thyroid disorders.

Publications

2021
Prevalence and characteristics of self-reported hypothyroidism and its association with nonorgan-specific manifestations in US sarcoidosis patients: a nationwide registry study.
ERJ open research. 7(1) [DOI] 10.1183/23120541.00754-2020. [PMID] 33816601.
2019
Pituitary Disorders in Pregnancy.
Neurologic clinics. 37(1):63-83 [DOI] 10.1016/j.ncl.2018.09.009. [PMID] 30470276.
2018
Screening for comorbid conditions in patients enrolled in the SODA registry: a 2-year observational analysis.
Endocrine. 61(1):105-117 [DOI] 10.1007/s12020-018-1615-3. [PMID] 29767287.
2017
A multicenter, observational study of lanreotide depot/autogel (LAN) in patients with acromegaly in the United States: 2-year experience from the SODA registry.
Pituitary. 20(6):605-618 [DOI] 10.1007/s11102-017-0821-y. [PMID] 28741071.
2017
Body Composition and Ectopic Lipid Changes With Biochemical Control of Acromegaly.
The Journal of clinical endocrinology and metabolism. 102(11):4218-4225 [DOI] 10.1210/jc.2017-01210. [PMID] 28945897.
2017
Stem cell therapy and its potential role in pituitary disorders.
Current opinion in endocrinology, diabetes, and obesity. 24(4):292-300 [DOI] 10.1097/MED.0000000000000346. [PMID] 28520591.
2016
A Benchmark for Preservation of Normal Pituitary Function After Endoscopic Transsphenoidal Surgery for Pituitary Macroadenomas.
World neurosurgery. 91:371-5 [DOI] 10.1016/j.wneu.2016.04.059. [PMID] 27113402.
2016
Functional Gonadotroph Adenomas: Case Series and Report of Literature.
Neurosurgery. 79(6):823-831 [PMID] 26692108.
View on: PubMed
2016
HIGH-DOSE BIOTIN TREATMENT FOR SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS MAY INTERFERE WITH THYROID ASSAYS.
AACE clinical case reports. 2(4):e370-e373 [PMID] 27917400.
View on: PubMed
2016
Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumors.
Oncotarget. 7(47):76565-76576 [DOI] 10.18632/oncotarget.12088. [PMID] 27655724.
2016
Pituitary Dysfunction After Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-analysis.
Neurosurgery. 79(2):253-64 [DOI] 10.1227/NEU.0000000000001157. [PMID] 26645970.
2015
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: POSTOPERATIVE MANAGEMENT FOLLOWING PITUITARY SURGERY.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 21(7):832-8 [DOI] 10.4158/EP14541.DSCR. [PMID] 26172128.
2015
Current indications for the surgical treatment of prolactinomas.
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. 22(11):1785-91 [DOI] 10.1016/j.jocn.2015.06.001. [PMID] 26277642.
2015
Incidence of primary cancers and intracranial tumour recurrences in GH-treated and untreated adult hypopituitary patients: analyses from the Hypopituitary Control and Complications Study.
European journal of endocrinology. 172(6):779-90 [DOI] 10.1530/EJE-14-1123. [PMID] 25810462.
2014
AACE/ACE Disease State Clinical Review: Dopamine Agonists for Hyperprolactinemia and the Risk of Cardiac Valve Disease.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 20(6):608-16 [DOI] 10.4158/EP14148.RA. [PMID] 24969114.
2014
AACE/ACE Disease State Clinical Review: Medical Management of Cushing Disease.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 20(7):746-57 [DOI] 10.4158/EP14147.RA. [PMID] 25057099.
2014
Expert consensus document: A consensus on the medical treatment of acromegaly.
Nature reviews. Endocrinology. 10(4):243-8 [DOI] 10.1038/nrendo.2014.21. [PMID] 24566817.
2014
Lanreotide extended-release aqueous-gel formulation, injected by patient, partner or healthcare provider in patients with acromegaly in the United States: 1-year data from the SODA registry.
Pituitary. 17(1):13-21 [DOI] 10.1007/s11102-012-0460-2. [PMID] 23314980.
2013
Determination of nadir growth hormone concentration cutoff in patients with acromegaly.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 19(6):937-45 [DOI] 10.4158/EP12435.OR. [PMID] 23807518.
2013
Incidence of second neoplasm in childhood cancer survivors treated with GH: an analysis of GeNeSIS and HypoCCS.
European journal of endocrinology. 168(4):565-73 [DOI] 10.1530/EJE-12-0967. [PMID] 23359434.
2013
Prospective safety surveillance of GH-deficient adults: comparison of GH-treated vs untreated patients.
The Journal of clinical endocrinology and metabolism. 98(3):980-8 [DOI] 10.1210/jc.2012-2684. [PMID] 23345098.
2013
Refractory pituitary granulomatosis with polyangiitis (Wegener’s) treated with rituximab.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 19(1):e1-7 [DOI] 10.4158/EP12181.CR. [PMID] 23186961.
2013
The postoperative cortisol stress response following transsphenoidal pituitary surgery: a potential screening method for assessing preserved pituitary function.
Pituitary. 16(3):319-25 [DOI] 10.1007/s11102-012-0423-7. [PMID] 22915289.
2011
Assessment of primary cancers in GH-treated adult hypopituitary patients: an analysis from the Hypopituitary Control and Complications Study.
European journal of endocrinology. 165(2):217-23 [DOI] 10.1530/EJE-11-0286. [PMID] 21646285.
2011
Atypical pituitary adenomas: incidence, clinical characteristics, and implications.
Journal of neurosurgery. 114(2):336-44 [DOI] 10.3171/2010.8.JNS10290. [PMID] 20868211.
2011
Prevalence and incidence of diabetes mellitus in adult patients on growth hormone replacement for growth hormone deficiency: a surveillance database analysis.
The Journal of clinical endocrinology and metabolism. 96(7):2255-61 [DOI] 10.1210/jc.2011-0448. [PMID] 21543424.
2010
Cushing’s disease and idiopathic intracranial hypertension: case report and review of underlying pathophysiological mechanisms.
The Journal of clinical endocrinology and metabolism. 95(11):4850-4 [DOI] 10.1210/jc.2010-0896. [PMID] 20739379.
2010
Metabolic, cardiovascular, and cerebrovascular outcomes in growth hormone-deficient subjects with previous cushing’s disease or non-functioning pituitary adenoma.
The Journal of clinical endocrinology and metabolism. 95(2):630-8 [DOI] 10.1210/jc.2009-0806. [PMID] 20022992.
2010
Occurrence of impaired fasting glucose in GH-deficient adults receiving GH replacement compared with untreated subjects.
Clinical endocrinology. 72(1):59-69 [DOI] 10.1111/j.1365-2265.2009.03612.x. [PMID] 19438908.
2010
Perioperative management of patients undergoing transsphenoidal pituitary surgery.
Asian journal of neurosurgery. 5(1):1-6 [PMID] 22028737.
View on: PubMed
2009
Changing patterns of the adult growth hormone deficiency diagnosis documented in a decade-long global surveillance database.
The Journal of clinical endocrinology and metabolism. 94(2):392-9 [DOI] 10.1210/jc.2008-0713. [PMID] 19001512.
2007
Single-dose rexinoid rapidly and specifically suppresses serum thyrotropin in normal subjects.
The Journal of clinical endocrinology and metabolism. 92(1):124-30 [PMID] 17062760.
View on: PubMed
2006
In the literature
. 10(7):31-34
2006
Pituitary tumors arising from glycoprotein hormone alpha-subunit-deficient mice contain transcription factors and receptors present in thyrotropes.
Pituitary. 9(1):11-8 [PMID] 16703404.
View on: PubMed
2006
The proliferative status of thyrotropes is dependent on modulation of specific cell cycle regulators by thyroid hormone.
Endocrinology. 147(1):272-82 [PMID] 16223861.
View on: PubMed
2005
Growth arrest of thyrotropic tumors by thyroid hormone is correlated with novel changes in Wnt-10A.
Molecular and cellular endocrinology. 238(1-2):57-67 [PMID] 15896901.
View on: PubMed
2005
Transcriptional regulation of somatostatin receptor genes
European Journal of Endocrinology. 152
2004
Silent corticotroph adenomas: further clinical and pathological observations.
Human pathology. 35(9):1137-47 [PMID] 15343517.
View on: PubMed
2004
Uses for recombinant human TSH in patients with thyroid cancer and nodular goiter.
Clinical endocrinology. 61(2):163-73 [PMID] 15272910.
View on: PubMed
2003
The management of subclinical hyperthyroidism by thyroid specialists.
Thyroid : official journal of the American Thyroid Association. 13(12):1133-9 [PMID] 14751034.
View on: PubMed
2002
Domains of Pit-1 required for transcriptional synergy with GATA-2 on the TSH beta gene.
Molecular and cellular endocrinology. 196(1-2):53-66 [PMID] 12385825.
View on: PubMed
2002
Early gene expression changes preceding thyroid hormone-induced involution of a thyrotrope tumor.
Endocrinology. 143(2):347-59 [PMID] 11796486.
View on: PubMed
2002
Mutational analysis of the mouse somatostatin receptor type 5 gene promoter.
Endocrinology. 143(6):2268-76 [PMID] 12021191.
View on: PubMed
2002
Towards improving the utility of fine-needle aspiration biopsy for the diagnosis of thyroid tumours.
Clinical endocrinology. 56(3):281-90 [PMID] 11940037.
View on: PubMed
2000
The effect of thyroid hormone and a long-acting somatostatin analogue on TtT-97 murine thyrotropic tumors.
Thyroid : official journal of the American Thyroid Association. 10(7):533-41 [PMID] 10958305.
View on: PubMed
1999
Cloning of the mouse somatostatin receptor subtype 5 gene: promoter structure and function.
Endocrinology. 140(12):5598-608 [PMID] 10579323.
View on: PubMed
1997
Systemic and renal hemodynamic changes in the luteal phase of the menstrual cycle mimic early pregnancy.
The American journal of physiology. 273(5):F777-82 [DOI] 10.1152/ajprenal.1997.273.5.F777. [PMID] 9374841.
1993
Factors that modulate inescapable shock-induced reductions in daily activity in the rat.
Pharmacology, biochemistry, and behavior. 45(3):553-9 [PMID] 8392730.
View on: PubMed
1990
Adinazolam both prevents and reverses the long-term reduction of daily activity produced by inescapable shock.
Pharmacology, biochemistry, and behavior. 36(4):767-73 [PMID] 2217504.
View on: PubMed
1988
Monoamine neurotransmitters and metabolites during the estrous cycle, pregnancy, and the postpartum period.
Pharmacology, biochemistry, and behavior. 30(3):563-8 [PMID] 3211964.
View on: PubMed
1988
The effects of stress and desipramine upon activity as a model of depression
. 97

Education

Fellowship – Endocrinology
1996-1999 · University of Colorado Health Sciences Center
Residency – Internal Medicine
1994-1996 · University of Colorado Health Sciences Center
Internship – Internal Medicine
1993-1994 · University of Colorado Health Sciences Center
MD
1993 · University of Colorado Health Sciences Center
MA Behavioral Neurosciences
1990 · University of Colorado, Boulder
BA Molecular Biology/Psychology
1987 · University of Colorado, Boulder

Teaching Profile

Courses Taught
2020
PAS5010 Intro to Medicine 1

Contact Details

Phones:
Business:
(352) 273-8655